Home  >  Products  >  LILRA5 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 ) Blocking Peptide (the N terminal of LILRA5)(100ug)
LILRA5 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 ) Blocking Peptide (the N terminal of LILRA5)(100ug)

LILRA5 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 ) Blocking Peptide (the N terminal of LILRA5)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LILRA5 Antibody (ARP66847_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66847
Size: 100ug
Weight: 29kDa
Gene: 353514
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family. LIR family members are known to have activating and inibitory functions in leukocytes. Crosslink of this receptor protein on the surface of monocytes has been shown to induce calcium flux and secretion of several proinflammatory cytokines, which suggests the roles of this protein in triggering innate immune responses. This gene is one of the leukocyte receptor genes that form a gene cluster on the chromosomal region 19q13.4. Four alternatively spliced transcript variants encoding distinct isoforms have been described.
Alternative names: CD85; CD85F; ILT11; LILRB7; LIR9
See Full Product Listings >